Elite Wealth Management Inc. Has $11.76 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Elite Wealth Management Inc. lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 23,935 shares of the medical equipment provider’s stock after selling 404 shares during the period. Intuitive Surgical comprises 1.6% of Elite Wealth Management Inc.’s portfolio, making the stock its 7th largest position. Elite Wealth Management Inc.’s holdings in Intuitive Surgical were worth $11,759,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. FMR LLC grew its position in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Fisher Asset Management LLC boosted its stake in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after acquiring an additional 86,208 shares during the period. Baillie Gifford & Co. grew its holdings in shares of Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares during the last quarter. American Century Companies Inc. raised its position in shares of Intuitive Surgical by 3.0% during the 2nd quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock worth $1,066,837,000 after purchasing an additional 70,556 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Intuitive Surgical by 1.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,227,467 shares of the medical equipment provider’s stock worth $1,094,288,000 after purchasing an additional 28,703 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Raymond James upped their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Robert W. Baird raised their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Price Performance

Shares of ISRG opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $304.50 and a 12-month high of $552.00. The stock has a market capitalization of $191.82 billion, a P/E ratio of 86.58, a P/E/G ratio of 5.28 and a beta of 1.39. The firm’s 50 day moving average is $507.94 and its 200-day moving average is $466.79.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity

In other news, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the sale, the general counsel now owns 1,595 shares in the company, valued at $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 238 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $477.50, for a total transaction of $113,645.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,629,115. This trade represents a 4.14 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,459 shares of company stock valued at $26,080,251 over the last three months. Insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.